Synexus looking for patients to take part in clinical studies to assess new treatments for osteoporosis, eczema and asthma

Synexus looking for patients to take part in clinical studies to assess new treatments for osteoporosis, eczema and asthma

Synexus, a company dedicated to the successful recruitment and running of clinical trials, is currently looking for patients to take part in a variety of studies to assess new treatments for osteoporosis, eczema and asthma at its Dedicated Research Centre in Manchester.

Osteoporosis

Osteoporosis is a condition that affects the bones, causing them to become weak and fragile and more likely to break (fracture). As a result, there are 230,000 fractures every year in the UK - most commonly occurring in the spine, wrist and hip. This can lead to loss of mobility, loss of independence and long term pain . Synexus is conducting a study to assess a new treatment that may help reduce the progression of Osteoporosis in Women.

This study may be suitable for ladies who: 

• Are aged between 60 – 90 
• Have already been diagnosed with osteoporosis 
• Have been treated with Alendronate / Fosamax or Fosavance for three or more years

Eczema

Eczema, also known as atopic dermatitis, causes dry skin and itchiness - symptoms felt by thousands on a daily basis. In the UK, one in 5 children and one in 12 adults suffer from Eczema . Creams and ointments applied to affected areas can help to relieve the symptoms. Synexus is currently involved in assessing a new ointment for this condition.

This study may be suitable for those:

• Aged 12 or over 
• Whose doctor has diagnosed eczema (atopic dermatitis)

Asthma

Asthma is a long-term condition that can cause a cough, wheezing and breathlessness due to inflammation of the airways. In the UK, 5.4 million people are currently receiving treatment for asthma - that’s 1 in every 12 adults and 1 in every 11 children . While there is no cure for asthma there are a number of treatments that can help control the condition.

The study that Synexus is running may be suitable for:

• Adults and children (aged 12 and over) who have asthma of any severity (e.g., mild, moderate or severe)
• Adults and children (aged 12 and over) who have had an acute asthma attack in the last year which has led to the need for oral steroids or a trip to hospital.

If you would like to find out more or are interested in participating in any of these studies contact 0161 662 5044 and quote reference number 16776.

There is no obligation for people to participate and if they do decide to take part, their GP will be kept fully informed of their involvement.

Patients may be reimbursed for reasonable out of pocket expenses if they are accepted onto one of the studies.

Participating in a Synexus clinical study means patients receive increased medical attention and may receive medications not yet available to other sufferers of their condition, while making a positive contribution to the health of future generations. 

For more information about Synexus visit www.improvinghealth.com